Picture of Agfa Gevaert NV logo

AGFB Agfa Gevaert NV News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Agfa Group FY EBITDA Up By 5%

March 9 (Reuters) - AGFA GEVAERT NV  AGFB.BR : 
    * GROUP TOPLINE 3% ABOVE 2020, WITH CONTRASTED DIVISIONAL
PERFORMANCES
    * FY ADJUSTED EBITDA 5% ABOVE 2020
    * STRONG PROFITABILITY PERFORMANCE OF HEALTHCARE IT
    * FY WORKING CAPITAL DECREASED TO 26% OF SALES DESPITE RAW
MATERIAL COST INFLATION AND SUPPLY CHAIN ISSUES
    * GROUP EXPECTS THAT UNCERTAINTY IN MOST OF ITS MARKETS WILL
CONTINUE WELL INTO 2022.
    * FY REVENUE EUR 1.76 BILLION VERSUS EUR 1.71 BILLION YEAR
AGO
    * HOWEVER, FOR FULL YEAR 2022, ALL DIVISIONS ARE EXPECTED TO
GROW
THEIR TOP LINE
    * FY NET LOSS OF 14 MILLION EURO
    * FOR HEALTHCARE IT DIVISION, 2022 WILL BE A YEAR OF
CONSOLIDATION
    * IN 2021, GROUP GENERATED A FREE CASH FLOW OF 8 MILLION
EURO,
BEFORE EXTRA PENSION FUNDING OF 130 MILLION EURO
    * ONGOING TRANSFORMATION ACTIONS ARE EXPECTED TO BRING MORE
AGILITY AND TO FURTHER SIMPLIFY OPERATIONS OF GROUP
    * THEY WILL ALSO ALLOW GROUP TO FURTHER REDUCE ITS COSTS
FROM 2023
ONWARDS
    * MORE RECENTLY, UKRAINE CRISIS CREATES NEW UNCERTAINTIES
GROUP IS
ASSESSING

Source text for Eikon:  urn:newsml:reuters.com:*:nGNE3K3nxH
Further company coverage:  AGFB.BR 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 772 09 20;))

Recent news on Agfa Gevaert NV

See all news